Cleared Traditional

VYGON LIFEVAC MID-LINE TRAY (K954112) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K954112 · Vygon Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1996
Decision
283d
Days
Class 2
Risk

K954112 is an FDA 510(k) clearance for the VYGON LIFEVAC MID-LINE TRAY. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Vygon Corp. (Elizabeth, US). The FDA issued a Cleared decision on May 9, 1996 after a review of 283 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Vygon Corp. devices

Submission Details

510(k) Number K954112 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 31, 1995
Decision Date May 09, 1996
Days to Decision 283 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 129d · This submission: 283d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 133
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K954112.
VAXESS PERIPHERALLY INSERTED CENTRAL CATHETER
K980566 · Boston Scientific Corp · Sep 1998
CVP POLYURETHANE CATHETER
K961552 · Abbott Laboratories · Feb 1997
0.9% SODIUM CHLORIDE DILUENT IN PLASTIC SYRINGE
K953805 · Abbott Laboratories · Jun 1996
ABRM CATHETER
K950118 · Cook, Inc. · Feb 1996
MAHURKAR DUAL LUMEN CATHETER
K943349 · Quinton, Inc. · Mar 1995
PRN ADAPTER
K933467 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 1994